Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 152-159, 2004. First published November 18, 2003; 10.1373/clinchem.2003.024323
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2003.024323v1
50/1/152    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (40)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Streit, F.
Right arrow Articles by Oellerich, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Streit, F.
Right arrow Articles by Oellerich, M.
Related Collections
Right arrow Drug Monitoring and Toxicology
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2004;50:152-159.)
© 2004 American Association for Clinical Chemistry, Inc.

Drug Monitoring and Toxicology

Validation of a Rapid and Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Free and Total Mycophenolic Acid

Frank Streit1, Maria Shipkova2, Victor William Armstrong1,a and Michael Oellerich1

1 Department of Clinical Chemistry, George-August University Gottingen, D-37075 Gottingen, Germany.
2 Central Institute for Clinical Chemistry and Laboratory Medicine, Klinikum Stuttgart, Stuttgart, Germany.

aAddress correspondence to this author at: Abteilung Klinische Chemie, Zentrum Innere Medizin, Georg-August-Universität Göttingen, Robert-Koch-Strasse 40, 37075 Göttingen, Germany. Fax 49-551-398551; e-mail varmstro{at}med.uni-goettingen.de.

Background: Because mycophenolic acid (MPA) is highly protein bound and because the free fraction is the pharmacologically active portion, a rapid, reliable, and sensitive procedure is required to study the relationship between free MPA and treatment efficacy/toxicity. Liquid chromatography–tandem mass spectrometry is ideally suited for such a method.

Methods: Free MPA was isolated from plasma by ultrafiltration. An online extraction cartridge with a column-switching technique, analytical liquid chromatography over an Aqua Perfect C18 column, and electrospray tandem mass spectrometry was used to quantify free and total MPA. To investigate ion suppression, a continuous infusion of MPA was introduced into the effluent from the HPLC column, and different ultrafiltrates and extracted plasma samples were injected on the column.

Results: A chromatographic run time of 4 min separated MPA from metabolites and internal standard, thereby avoiding interference from in-source fragmentation. Ion suppression occurred well before elution of MPA and internal standard. The lower limit of quantification for free MPA was 0.5 µg/L, and the method was linear to 1000 µg/L. Interassay imprecision (CV) was <10% for free MPA (0.5–333 µg/L). Agreement was good for free MPA (n = 52) and total MPA (n = 106) between the proposed method and a validated HPLC method with ultraviolet detection. The Passing–Bablok regression line was: y = 0.95x + 0.27 µg/L for free MPA and y = 0.98x + 0.03 mg/L for total MPA.

Conclusions: The presented method allows the accurate, precise, and rapid determination of free and total MPA in plasma over a wide analytical range covering the concentrations relevant to pharmacokinetic studies and routine monitoring of this drug.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
J. Kuhn, C. Prante, S. Schon, C. Gotting, and K. Kleesiek
Measurement of Fibrosis Marker Xylosyltransferase I Activity by HPLC Electrospray Ionization Tandem Mass Spectrometry
Clin. Chem., December 1, 2006; 52(12): 2243 - 2249.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. Brandhorst, F. Streit, S. Goetze, M. Oellerich, and V. W. Armstrong
Quantification by Liquid Chromatography Tandem Mass Spectrometry of Mycophenolic Acid and Its Phenol and Acyl Glucuronide Metabolites
Clin. Chem., October 1, 2006; 52(10): 1962 - 1964.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
X. Cussonneau, M. Bolon-Larger, and R. Boulieu
Adsorption of Mycophenolic Acid and Its Phenolic Glucuronide to Glass, Polystyrene, and Polypropylene Containers.
Clin. Chem., May 1, 2006; 52(5): 904 - 906.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. M. Annesley and L. T. Clayton
Quantification of Mycophenolic Acid and Glucuronide Metabolite in Human Serum by HPLC-Tandem Mass Spectrometry
Clin. Chem., May 1, 2005; 51(5): 872 - 877.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
L. Anderson
Candidate-based proteomics in the search for biomarkers of cardiovascular disease
J. Physiol., February 15, 2005; 563(1): 23 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Kinter
Toward Broader Inclusion of Liquid Chromatography-Mass Spectrometry in the Clinical Laboratory
Clin. Chem., September 1, 2004; 50(9): 1500 - 1502.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.